Tell your friends about this item:
Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy Elisabeth Bergen 2011 edition
Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy
Elisabeth Bergen
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors.
110 pages, biography
| Media | Books Paperback Book (Book with soft cover and glued back) |
| Released | February 25, 2013 |
| ISBN13 | 9783034803182 |
| Publishers | Springer Basel |
| Pages | 110 |
| Dimensions | 155 × 235 × 7 mm · 181 g |
| Language | German |
| Editor | Bartsch, Rupert |
| Editor | Grunt, Thomas W. |
| Editor | Sibilia, Maria |
| Editor | Zielinski, Christoph C. |
See all of Elisabeth Bergen ( e.g. Paperback Book )
Christmas presents can be returned until 31 January